Mitsuhito Mase Selected Research

NMS60

6/2006

Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent: early phase II study in brain tumors and dual dynamic contrast-enhanced imaging.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsuhito Mase Research Topics

Disease

4	Neoplasms (Cancer) 01/2020 - 06/2006
3	Stroke (Strokes) 02/2022 - 09/2009
3	Pathologic Constriction (Stenosis) 06/2017 - 01/2014
3	Carotid Stenosis (Carotid Artery Stenosis) 06/2017 - 12/2012
2	Cerebral Infarction 02/2022 - 01/2021
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2022 - 07/2004
2	Normal Pressure Hydrocephalus 04/2014 - 12/2003
2	Hematoma 09/2009 - 01/2006
2	Chronic Subdural Hematoma 09/2009 - 01/2006
1	Thrombosis (Thrombus) 02/2022
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 02/2022
1	Paralysis (Palsy) 01/2022
1	Crush Injuries 01/2022
1	Peripheral Nerve Injuries 01/2022
1	Vascular Calcification 01/2020
1	Giant Cell Tumors (Giant Cell Tumor) 01/2020
1	Giant Cell Tumor of Bone 01/2020
1	Atherosclerosis 01/2020
1	Craniopharyngioma (Craniopharyngiomas) 01/2018
1	Headache (Headaches) 12/2017
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 09/2014
1	Alzheimer Disease (Alzheimer's Disease) 04/2014
1	Cognitive Dysfunction 01/2013
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2013
1	Infarction (Infarctions) 07/2011
1	Hypoxia (Hypoxemia) 09/2009
1	Brain Neoplasms (Brain Tumor) 06/2006

Drug/Important Bio-Agent (IBA)

3	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 09/2014 - 12/2003
3	LipocalinsIBA 09/2014 - 12/2003
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2006
2	CalciumIBA 06/2017 - 01/2014
2	EnzymesIBA 04/2014 - 09/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2009 - 01/2006
1	GlucocorticoidsIBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Denosumab FDA Link 01/2020
1	Kallikreins (Kallikrein)IBA 01/2020
1	LigandsIBA 01/2020
1	A-factor (Streptomyces)IBA 12/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	Biliverdine (Biliverdin)IBA 09/2014
1	Amyloid beta-PeptidesIBA 04/2014
1	ProstaglandinsIBA 04/2014
1	Oxyhemoglobins (Oxyhemoglobin)IBA 01/2013
1	Inosine Monophosphate (IMP)IBA 12/2012
1	Acetazolamide (Diamox)FDA LinkGeneric 12/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 09/2009
1	Sepharose (Agarose)IBA 09/2009
1	ImmunosorbentsIBA 09/2009
1	Contrast MediaIBA 06/2006
1	NMS60IBA 06/2006
1	plasmin-plasmin inhibitor complexIBA 01/2006
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2006
1	myelencephalon-specific serine proteaseIBA 07/2004

Therapy/Procedure

3	Carotid Endarterectomy 06/2017 - 01/2014
2	Thrombectomy 02/2022 - 02/2022
2	Stents 01/2017 - 01/2014
1	Catheters 02/2022
1	Therapeutics 02/2022
1	Anesthesia 01/2022
1	Aftercare (After-Treatment) 01/2021
1	Craniotomy 01/2018
1	Decompression 01/2018
1	Operative Surgical Procedures 12/2017
1	Cognitive Training 01/2013
1	Microspheres (Microsphere) 07/2011